As expected, compared with IMQ-treated mice that received control MDSCs, IMQ-treated mice that received lupus MDSCs showed significantly higher levels of CD86 on splenic macrophages (Fig. 1G) and DCs (Fig. 1H). The gene discussed is CD86; the disease is systemic lupus erythematosus.